Published in J Clin Invest on July 01, 1991
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med (1988) 8.01
Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest (1989) 3.34
The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem (1989) 3.14
High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. Science (1986) 2.50
Model of alpha 2-macroglobulin structure and function. Proc Natl Acad Sci U S A (1985) 1.79
Thrombin specificity. Ann N Y Acad Sci (1981) 1.55
Anti-prothrombin antibodies and the lupus anticoagulant. Blood (1988) 1.22
Human alpha-thrombin binding to nonpolymerized fibrin-Sepharose: evidence for an anionic binding region. Biochemistry (1985) 1.22
Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition. Biochemistry (1988) 1.20
The effect of bovine thrombomodulin on the specificity of bovine thrombin. J Biol Chem (1986) 1.12
Covalent structures of beta and gamma autolytic derivatives of human alpha-thrombin. J Biol Chem (1984) 1.11
Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. J Clin Invest (1987) 1.07
Proflavin binding within the fibrinopeptide groove adjacent to the catalytic site of human alpha-thrombin. Biochemistry (1984) 1.07
Myositis autoantibody reactivity and catalytic function of threonyl-tRNA synthetase. FASEB J (1988) 1.02
Comparison of the inhibition of thrombin by three plasma protease inhibitors. Biochemistry (1978) 1.01
The use of sequence-specific antibodies to identify a secondary binding site in thrombin. J Biol Chem (1988) 1.01
Human autoantibodies to poly(adenosine diphosphate-ribose) polymerase. J Clin Invest (1987) 0.99
Physical evidence for an apolar binding site near the catalytic center of human alpha-thrombin. Biochemistry (1977) 0.96
Preparation and characterization of proteolyzed forms of human alpha-thrombin. Thromb Res (1988) 0.95
The effect of phospholipids on the activation of protein C by the human thrombin-thrombomodulin complex. Biochem J (1986) 0.94
The structures and proteolytic specificities of autolysed human thrombin. Biochem J (1986) 0.93
Thrombin active-site regions. Semin Thromb Hemost (1986) 0.93
Protease inhibitors of human plasma. Alpha-2-macroglobulin. J Med (1985) 0.93
Immunoglobulin allotyping (Gm, Km) of GAW5 families. Genet Epidemiol (1989) 0.90
Interaction of human alpha-thrombin and gamma-thrombin with antithrombin III, protein C and thrombomodulin. Eur J Biochem (1985) 0.89
Isolation and characterization of an acquired antithrombin antibody. Blood (1990) 0.89
Enzymic and nonenzymic properties of human beta-thrombin. J Biol Chem (1988) 0.88
Stability of the thrombin-thrombomodulin complex on the surface of endothelial cells from human saphenous vein or from the cell line EA.hy 926. Biochem J (1989) 0.87
Difference in enzymatic properties between alpha-thrombin-staphylocoagulase complex and free alpha-thrombin. J Biochem (1985) 0.85
Cross-linking of alpha and gamma-thrombin to distinct binding sites on human platelets. Eur J Biochem (1988) 0.84
Human autoantibodies to poly(adenosine diphosphate-ribose) polymerase recognize cross-reactive epitopes associated with the catalytic site of the enzyme. J Clin Invest (1989) 0.81
Active-site topography of human coagulant (alpha) and noncoagulant (beta) thrombins. Biochemistry (1981) 0.79
Microheterogeneity in the major phenobarbital-inducible forms of rabbit liver microsomal cytochrome P-450 as revealed by nucleotide sequencing of cloned cDNAs. Biochemistry (1988) 0.79
A computer-generated three-dimensional model of the B chain of bovine alpha-thrombin. Ann N Y Acad Sci (1981) 0.77
Spontaneous antithrombin in a patient with benign paraprotein. Am J Hematol (1987) 0.76
Interaction of alpha 2-macroglobulin-bound thrombin with hirudin. FEBS Lett (1984) 0.76
CRYOCOAGULOPATHY WITH PRESENCE OF IMMUNOANTITHROMBIN IN THE COURSE OF LUPUS ERYTHEMATOSUS DISSEMINATUS. Acta Med Pol (1964) 0.76
An acquired coagulation inhibitor to factor II. Br J Haematol (1982) 0.76
Acquired thrombin inhibitor in a patient with liver cirrhosis. Haemostasis (1985) 0.76
The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol (2001) 3.92
The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol (1999) 3.22
Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology (2000) 3.16
Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation (2000) 3.08
Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum (2001) 2.96
Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology (2001) 2.75
Measuring circulating cell-derived microparticles. J Thromb Haemost (2004) 2.61
The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest (1995) 2.37
The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. J Clin Invest (1993) 2.37
Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol (2014) 2.28
ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol (2000) 2.25
Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis (2004) 2.15
Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation (1999) 1.89
Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood (1996) 1.89
In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol (2000) 1.77
High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called 'antikeratin antibodies'. Ann Rheum Dis (1989) 1.69
Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol (1994) 1.66
Letter: Factor-VIII complex and endothelial damage. Lancet (1975) 1.61
Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight. Thromb Haemost (2001) 1.60
Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol (1998) 1.59
Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology (1986) 1.59
Oriented fibrin gels formed by polymerization in strong magnetic fields. Nature (1981) 1.49
Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood (1993) 1.48
Prevalence and significance of anticardiolipin antibodies in Crohn's disease. Dig Dis Sci (1994) 1.47
The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest (1997) 1.43
A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann Rheum Dis (2004) 1.36
Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies. J Clin Microbiol (1996) 1.35
Aspirin and recurrent painful toes and fingers in thrombocythaemia. Lancet (1972) 1.33
Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides. Ann Rheum Dis (1999) 1.30
Formation of two-dimensional arrays of annexin V on phosphatidylserine-containing liposomes. J Mol Biol (1994) 1.29
Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol. J Am Coll Cardiol (2000) 1.22
Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand J Infect Dis (1998) 1.19
[Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial]. Rev Neurol (Paris) (1982) 1.18
Factor V Leiden related Budd-Chiari syndrome. Gut (2001) 1.17
Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood (1999) 1.16
Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Ann Rheum Dis (2001) 1.15
Characterisation of the rat oesophagus epithelium antigens defined by the so-called 'antikeratin antibodies', specific for rheumatoid arthritis. Ann Rheum Dis (1993) 1.13
Arterial thrombosis and protein S deficiency. Thromb Haemost (1989) 1.13
IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Clin Exp Immunol (2005) 1.10
Refined characterization of corneodesmosin proteolysis during terminal differentiation of human epidermis and its relationship to desquamation. J Biol Chem (2001) 1.08
The peptidylarginine deiminases expressed in human epidermis differ in their substrate specificities and subcellular locations. Cell Mol Life Sci (2005) 1.08
Enhancement of enzymatic fibrinolysis with 2-MHz ultrasound and microbubbles. J Thromb Haemost (2004) 1.08
Thrombin regulates tissue factor and thrombomodulin mRNA levels and activities in human saphenous vein endothelial cells by distinct mechanisms. J Biol Chem (1993) 1.08
Effects of lysophosphatidic acid on proliferation and cytosolic Ca++ of human adult vascular smooth muscle cells in culture. Thromb Res (1999) 1.07
Natural IgM and IgG autoantibodies to epidermal keratins in normal human sera. I: ELISA-titration, immunofluorescence study. J Invest Dermatol (1987) 1.07
The complex and diversified mitochondrial gene pool of Berber populations. Ann Hum Genet (2008) 1.06
Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial. World J Surg (1997) 1.06
The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin. Biochem J (1987) 1.05
Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions. Br J Cancer (1999) 1.05
Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+-ATPase inhibitors. Biochemistry (1995) 1.05
Antifilaggrin antibodies in early rheumatoid arthritis may predict radiological progression. Scand J Rheumatol (2001) 1.05
Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation (2001) 1.03
Pharmacokinetics of heparin and low molecular weight heparin. Baillieres Clin Haematol (1990) 1.03
An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity--a mechanism for thrombosis. Thromb Haemost (1986) 1.03
Sub-domain structure of lipid-bound annexin-V resolved by electron image analysis. J Mol Biol (1991) 1.02
In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol (1997) 1.02
High levels of cytokeratin 19 fragments but no evidence of cytokeratins 1, 2, 10/11, 14 or filaggrin in the serum of squamous cell lung carcinoma patients. Tumour Biol (2000) 1.01
Effects of brief early exposure to partially hydrolyzed and whole cow milk proteins. J Pediatr (1992) 1.01
Isotypic characterization of anti-Toxoplasma gondii antibodies in 18 cases of congenital toxoplasmic chorioretinitis. Acta Ophthalmol (Copenh) (1989) 1.01
[Anti-stratum corneum antibody in the rat esophagus, anti-epidermal keratin and anti-epidermis autoantibodies in rheumatoid polyarthritis and other rheumatic diseases. Diagnostic value and basic aspects]. Rev Rhum Mal Osteoartic (1986) 1.00
Human factor VIII procoagulant activity and phospholipid interaction. Biochim Biophys Acta (1981) 1.00
Immunocytochemical evidence for a possible role of cross-linked keratinocyte envelopes in stratum corneum cohesion. J Histochem Cytochem (1991) 1.00
The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin. Blood (1985) 0.98
Regulation of phosphatidylserine transbilayer redistribution by store-operated Ca2+ entry: role of actin cytoskeleton. J Biol Chem (2000) 0.97
Evidence that filaggrin is a component of cornified cell envelopes in human plantar epidermis. Biochem J (1996) 0.97
Absence of the hemochromatosis gene Cys282Tyr mutation in three ethnic groups from Algeria (Mzab), Ethiopia, and Senegal. Immunogenetics (1997) 0.97
Antifilaggrin autoantibodies in early rheumatoid arthritis. Scand J Rheumatol (2000) 0.96
Nine procaspases are expressed in normal human epidermis, but only caspase-14 is fully processed. Br J Dermatol (2007) 0.96
Evaluation of five hepatitis delta virus marker assays for detection of antigen and antibody. J Clin Microbiol (1989) 0.96
Update on peptidylarginine deiminases and deimination in skin physiology and severe human diseases. Int J Cosmet Sci (2007) 0.95
Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation (2000) 0.95
Annexin V delays apoptosis while exerting an external constraint preventing the release of CD4+ and PrPc+ membrane particles in a human T lymphocyte model. J Immunol (1999) 0.95
Prenatal diagnosis of congenital toxoplasmosis transmitted by an immunocompetent woman infected before conception. Reims Toxoplasmosis Group. Prenat Diagn (1998) 0.95
Fibrinogen and fibrin structure and fibrin formation measured by using magnetic orientation. Proc Natl Acad Sci U S A (1983) 0.94
The effect of phospholipids on the activation of protein C by the human thrombin-thrombomodulin complex. Biochem J (1986) 0.94
Molecular cloning and expression of bothrojaracin, a potent thrombin inhibitor from snake venom. Eur J Biochem (1997) 0.94
Immunophenotyping of mesothelial cells and carcinoma cells with monoclonal antibodies to cytokeratins, vimentin, CEA and EMA improves the cytodiagnosis of serous effusions. Cytopathology (1991) 0.94
Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol (1993) 0.93
Bothrojaracin, a new thrombin inhibitor isolated from Bothrops jararaca venom: characterization and mechanism of thrombin inhibition. Biochemistry (1993) 0.93
Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells. Biochem J (1992) 0.93
An equilibrium study of metal ion binding to human plasma coagulation factor XIII. Biochem J (1978) 0.93
A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. Br J Haematol (1999) 0.93
Natural IgG to epidermal cytokeratins vs IgG to the stratum corneum of the rat oesophagus epithelium, so-called 'antikeratin antibodies', in rheumatoid arthritis and other rheumatic diseases. J Autoimmun (1991) 0.93
Immunoblotting detection of so-called 'antikeratin antibodies': a new assay for the diagnosis of rheumatoid arthritis. Ann Rheum Dis (1994) 0.92
Prenatal diagnosis of congenital toxoplasmosis in 261 pregnancies. Prenat Diagn (1997) 0.92
A simple method to measure dermatan sulfate at sub-microgram concentrations in plasma. Thromb Haemost (1988) 0.92
Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis. Ann Rheum Dis (2007) 0.92
Protein-protein interactions in blood clotting. The use of polarization of fluorescence to measure the dissociation of plasma factor XIIIa. Biochem J (1978) 0.92
Corneodesmosin expression in psoriasis vulgaris differs from normal skin and other inflammatory skin disorders. Lab Invest (2001) 0.92
[Early diagnosis and surveillance of congenital toxoplasmosis. The comparative immunological profiles method]. Presse Med (1987) 0.92
Defect in the gamma polypeptide chain of a congenital abnormal fibrinogen (Paris I). Nature (1974) 0.92
Influence of digital rectal massage on urinary prostate-specific antigen: interest for the detection of local recurrence after radical prostatectomy. Prostate (1998) 0.92
Subclass distribution of IgG antibodies to the rat oesophagus stratum corneum (so-called anti-keratin antibodies) in rheumatoid arthritis. Clin Exp Immunol (1990) 0.92
The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide. Br J Haematol (1997) 0.91
The antiperinuclear factor and antikeratin antibody systems. Int Arch Allergy Immunol (1995) 0.91
Detection of specific immunoglobulin E during maternal, fetal, and congenital toxoplasmosis. J Clin Microbiol (1999) 0.91